Literature DB >> 31634414

Gene Editing to Generate Versatile Human Pluripotent Stem Cell Reporter Lines for Analysis of Differentiation and Lineage Tracing.

Xiaoping Bao1,2,3, Maroof M Adil1,2, Riya Muckom1,2, Joshua A Zimmermann1,2, Aurelie Tran4, Natalie Suhy4, Yibo Xu3, Rocío G Sampayo1,2, Douglas S Clark2,5, David V Schaffer1,2,3,4.   

Abstract

Transcription factors (TFs) are potent proteins that control gene expression and can thereby drive cell fate decisions. Fluorescent reporters have been broadly knocked into endogenous TF loci to investigate the biological roles of these factors; however, the sensitivity of such analyses in human pluripotent stem cells (hPSCs) is often compromised by low TF expression levels and/or reporter silencing. Complementarily, we report an inducible and quantitative reporter platform based on the Cre-LoxP recombination system that enables robust, quantifiable, and continuous monitoring of live hPSCs and their progeny to investigate the roles of TFs during human development and disease. Stem Cells 2019;37:1556-1566. ©AlphaMed Press 2019.

Entities:  

Keywords:  CRISPR/Cas9; Fate mapping; Gene editing; Human pluripotent stem cells; Transcription factors

Mesh:

Substances:

Year:  2019        PMID: 31634414     DOI: 10.1002/stem.3096

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  6 in total

1.  Fluorescent indicators for continuous and lineage-specific reporting of cell-cycle phases in human pluripotent stem cells.

Authors:  Yun Chang; Peter B Hellwarth; Lauren N Randolph; Yufei Sun; Yuxian Xing; Wuqiang Zhu; Xiaojun Lance Lian; Xiaoping Bao
Journal:  Biotechnol Bioeng       Date:  2020-04-22       Impact factor: 4.530

2.  High-throughput 3D screening for differentiation of hPSC-derived cell therapy candidates.

Authors:  Riya Muckom; Xiaoping Bao; Eric Tran; Evelyn Chen; Abirami Murugappan; Jonathan S Dordick; Douglas S Clark; David V Schaffer
Journal:  Sci Adv       Date:  2020-08-07       Impact factor: 14.136

3.  Downregulation of miR-23b by transcription factor c-Myc alleviates ischemic brain injury by upregulating Nrf2.

Authors:  Rui Xin; Danhua Qu; Shuang Su; Bin Zhao; Dawei Chen
Journal:  Int J Biol Sci       Date:  2021-08-26       Impact factor: 6.580

4.  Engineering chimeric antigen receptor neutrophils from human pluripotent stem cells for targeted cancer immunotherapy.

Authors:  Yun Chang; Ramizah Syahirah; Xuepeng Wang; Gyuhyung Jin; Sandra Torregrosa-Allen; Bennett D Elzey; Sydney N Hummel; Tianqi Wang; Can Li; Xiaojun Lian; Qing Deng; Hal E Broxmeyer; Xiaoping Bao
Journal:  Cell Rep       Date:  2022-07-19       Impact factor: 9.995

Review 5.  Modeling blood-brain barrier pathology in cerebrovascular disease in vitro: current and future paradigms.

Authors:  Anuska V Andjelkovic; Svetlana M Stamatovic; Chelsea M Phillips; Gabriela Martinez-Revollar; Richard F Keep
Journal:  Fluids Barriers CNS       Date:  2020-07-16

6.  Optogenetic Control of Engrafted Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Live Mice: A Proof-of-Concept Study.

Authors:  Jyotsna Joshi; Bing Xu; Michael Rubart; Yun Chang; Xiaoping Bao; Hari P Chaliki; Luis R Scott; Wuqiang Zhu
Journal:  Cells       Date:  2022-03-10       Impact factor: 7.666

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.